Altogether, these results indicate that activation of IGF1R signaling promotes EMP and tumor progression toward a mesenchymal state in an ITGAV-mediated process, which facilitates the response to TME-derived factors, such as TGFβ. This evidence concerns the gene IGF1R and neoplasm.